Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

Abstract

OCCLUSION of the diseased coronary artery in humans causes acute myocardial infarction, survivors of which have a high risk for the development of chronic heart failure1. Cardiac myocytes and vascular endothelial cells produce endothelin-1 (refs 2–4), which increases the contractility of cardiac muscle and of vascular smooth muscle cells2,3,5. Endothelin-1 also exerts long-term effects such as myocardial hypertrophy, and causes cellular injury in cardiac myocytes3,5–7. Production of endothelin-1 is markedly increased in the myocardium of rats with heart failure, and acute application of an endothelin-receptor antagonist decreases myocardial contractility in such rats, indicating that myocardial endothelin-1 may help to support contractility of the failing heart8. But we report here that the upregulated myocardial endothelin system may contribute to the progression of chronic heart failure, because long-term treatment with an endothelin-receptor antagonist greatly improved the survival of rats with chronic heart failure. This beneficial effect was accompanied by significant amelioration of left ventricular dysfunction and prevention of ventricular remodelling, in which there is usually an increase in the ventricular mass and cavity enlargement of the ventricle.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Pfeffer, M. A. Annu. Rev. Med. 46, 455–466 (1995).

    Article  CAS  Google Scholar 

  2. Yanagisawa, M. et al. Nature 332, 411–415 (1988).

    Article  ADS  CAS  Google Scholar 

  3. Rubanyi, G. M. & Polokoff, M. A. Pharmacol. Rev. 45, 325–415 (1994).

    Google Scholar 

  4. Suzuki, T. et al. Biochem. Biophys. Res. Commun. 193, 823–830 (1993).

    Article  Google Scholar 

  5. Goto, K. & Warner, T. D. Nature 375, 539–540 (1995).

    Article  ADS  CAS  Google Scholar 

  6. Miyauchi, T. et al. Circ. Res. 73, 887–897 (1993).

    Article  CAS  Google Scholar 

  7. Prasad, M. R. Biochem. Biophys. Res. Commun. 174, 952–957 (1991).

    Article  CAS  Google Scholar 

  8. Sakai, S. et al. Circulation 93, 1214–1222 (1996).

    Article  CAS  Google Scholar 

  9. Pfeffer, M. A. et al. Circ. Res. 44, 503–512 (1979).

    Article  CAS  Google Scholar 

  10. Pfeffer, J. M. et al. Annu. Rev. Physiol. 57, 805–826 (1995).

    Article  CAS  Google Scholar 

  11. Ihara, M. et al. Life Sci. 50, 247–255 (1992).

    Article  CAS  Google Scholar 

  12. Melillo, G. et al. Circulation 93, 1447–1458 (1996).

    Article  CAS  Google Scholar 

  13. Molenaar, P. et al. Circ. Res. 72, 526–538 (1993).

    Article  CAS  Google Scholar 

  14. Packer, M. et al. N. Engl. J. Med. 325, 1468–1475 (1991).

    Article  CAS  Google Scholar 

  15. Katz, A. M. Circulation 73, III-184–III-188 (1986).

    CAS  Google Scholar 

  16. Yorikane, R. & Koike, H. Jpn J. Pharmacol. 53, 259–263 (1990).

    Article  CAS  Google Scholar 

  17. Yorikane, R. et al. FEBS Lett. 332, 31–34 (1993).

    Article  CAS  Google Scholar 

  18. Kiowski, W. et al. Lancet 346, 732–736 (1995).

    Article  CAS  Google Scholar 

  19. Ishikawa, S., Miyauchi, T. et al. J. Thorac. Cardiovasc. Surg. 110, 271–273 (1995).

    Article  CAS  Google Scholar 

  20. Stewart, D. J. et al. Circulation 85, 510–517 (1992).

    Article  CAS  Google Scholar 

  21. Kobayashi, M. et al. Acta Histochem. Cytochem. 28, 129–136 (1995).

    Article  CAS  Google Scholar 

  22. Miyauchi, T. et al. Lancet ii, 53–54 (1989).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakai, S., Miyauchi, T., Kobayashi, M. et al. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384, 353–355 (1996). https://doi.org/10.1038/384353a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/384353a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing